Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2025-12-24 @ 2:54 PM
NCT ID:
NCT02817659
Brief Summary:
To further understand the tolerability of glucagon.
Detailed Description:
To determine the tolerability of glucagon infusion administered in an escalating step-wise manner in healthy obese subjects
Study:
NCT02817659
Study Brief:
Protocol Section:
NCT02817659